speb/financial-data huggingface dataset:
MRZ.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 81101494.00
MRZ.V income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.04
MRZ.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2884159.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 33930.00
MRZ.V income_statement (quarterly, 2025-03-31) — EBIT: -2880060.00
MRZ.V income_statement (quarterly, 2025-03-31) — EBITDA: -2867319.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -15754.00
MRZ.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 1842269.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 986853.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2244157.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
MRZ.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -17211.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 23668723.00
MRZ.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 231216.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1899688.00
MRZ.V income_statement (quarterly, 2025-03-31) — Gross Profit: -12741.00
MRZ.V income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
MRZ.V income_statement (quarterly, 2025-03-31) — Interest Expense: 4099.00
MRZ.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 4099.00
MRZ.V income_statement (quarterly, 2025-03-31) — Interest Income: 27424.00
MRZ.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 27424.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 811.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 27076.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2606603.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -39261.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -13147.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -16429.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2884159.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2884159.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 23325.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 986853.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -13147.00
MRZ.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 23325.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 1680883.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -66337.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 1000000.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1603315.00
MRZ.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2850108.00
MRZ.V income_statement (quarterly, 2025-03-31) — Normalized Income: -2866948.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2177820.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -16429.00
MRZ.V income_statement (quarterly, 2025-03-31) — Operating Income: -2906478.00
MRZ.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 81101494.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1003288.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 23668723.00
MRZ.V income_statement (quarterly, 2025-03-31) — Other Gand A: 58621.00
MRZ.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -1006.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -7121.00
MRZ.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 16205.00
MRZ.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 2552818.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 1899688.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 82617.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 36323.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1130086.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 58612.00
MRZ.V income_statement (quarterly, 2025-03-31) — Pretax Income: -2884159.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -66337.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Receivables: 126002.00
MRZ.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 12741.00
MRZ.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12741.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -13147.00
MRZ.V income_statement (quarterly, 2025-03-31) — Research And Development: -4947.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -94412736.00
MRZ.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 172595.00
MRZ.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 114650.00
MRZ.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 345866.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 81101494.00
MRZ.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 153695.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1603315.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1603315.00
MRZ.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MRZ.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 5705.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 3744089.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1603315.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 1010688.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1603315.00
MRZ.V income_statement (quarterly, 2025-03-31) — Total Expenses: 2906478.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2140774.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1680883.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MRZ.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -17211.00
MRZ.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -17211.00
MRZ.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
MRZ.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -77568.00
MRZ.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 910428.00
MRZ.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1040242.00
MRZ.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 81851494.00
MRZ.V income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
MRZ.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1633072.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 44374.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 74594675.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 527334.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 594791.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -11417.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 1588.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1096065.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -268265.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 8628.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -259637.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -2004.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1105894.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 74594675.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -1198196.00
MRZ.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 15619.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 717259.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 44374.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 2894218.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2938592.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3435211.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Depreciation: 15619.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 15619.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 15619.00
MRZ.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 81851494.00
MRZ.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
MRZ.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1033077.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 25791.00
MRZ.V income_statement (quarterly, 2025-09-30) — EBIT: -954297.00
MRZ.V income_statement (quarterly, 2025-09-30) — EBITDA: -938678.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 156.00
MRZ.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 527334.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -11417.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1096065.00
MRZ.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 30234.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 21949669.00
MRZ.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 121141.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2559998.00
MRZ.V income_statement (quarterly, 2025-09-30) — Gross Profit: -15619.00
MRZ.V income_statement (quarterly, 2025-09-30) — Interest Expense: 78780.00
MRZ.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 78780.00
MRZ.V income_statement (quarterly, 2025-09-30) — Interest Income: 2493.00
MRZ.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2493.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 2113.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 1588.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1696022.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 1588.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -11417.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 104126.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 2366884.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -25850.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1033077.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1033077.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -152537.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -11417.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -11417.00
MRZ.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -152537.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 1519756.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1198196.00
MRZ.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -968912.00
MRZ.V income_statement (quarterly, 2025-09-30) — Normalized Income: -1063311.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1096065.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -25850.00
MRZ.V income_statement (quarterly, 2025-09-30) — Operating Income: -926047.00
MRZ.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 81851494.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 2894218.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 21949669.00
MRZ.V income_statement (quarterly, 2025-09-30) — Other Gand A: 55015.00
MRZ.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 45507.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 167810.00
MRZ.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 15273.00
MRZ.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 717356.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 262904.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 39016.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 67457.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 496619.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 50727.00
MRZ.V income_statement (quarterly, 2025-09-30) — Pretax Income: -1033077.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Receivables: 71741.00
MRZ.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 15619.00
MRZ.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 15619.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -11417.00
MRZ.V income_statement (quarterly, 2025-09-30) — Research And Development: 30773.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -97742540.00
MRZ.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 66126.00
MRZ.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 41158.00
MRZ.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 162299.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 81851494.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 59826.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -1198196.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1198196.00
MRZ.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MRZ.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 6934.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 2237015.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1198196.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 2938592.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -1198196.00
MRZ.V income_statement (quarterly, 2025-09-30) — Total Expenses: 926047.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3435211.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1519756.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
MRZ.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 76250.00
MRZ.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 30234.00
MRZ.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 30234.00
MRZ.V cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -20756.00
MRZ.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -2717952.00
MRZ.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 2248517.00
MRZ.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1056437.00
MRZ.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 82396829.00
MRZ.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 527334.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 25828.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 77245567.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2246642.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2340046.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 973948.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2124842.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1379880.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 350861.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -43882.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 306979.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -9671.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1718910.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 77245567.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1822722.00
MRZ.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 16194.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 2495345.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 25828.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 1136233.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1162061.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2009541.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Depreciation: 16195.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 16195.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 16195.00
MRZ.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 82396829.00
MRZ.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
MRZ.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8151.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 41626.00
MRZ.V income_statement (quarterly, 2025-12-31) — EBIT: 57172.00
MRZ.V income_statement (quarterly, 2025-12-31) — EBITDA: 73367.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 398.00
MRZ.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 2246642.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 138665.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 973948.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1379880.00
MRZ.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 1810640.00
MRZ.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 452817.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 22327846.00
MRZ.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 129904.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2254690.00
MRZ.V income_statement (quarterly, 2025-12-31) — Gross Profit: -16194.00
MRZ.V income_statement (quarterly, 2025-12-31) — Interest Expense: 65323.00
MRZ.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 65323.00
MRZ.V income_statement (quarterly, 2025-12-31) — Interest Income: 9509.00
MRZ.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 9509.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: -2113.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 8894.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2958955.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2124842.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 138665.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 138665.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -11417.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 104126.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 21565.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8151.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8151.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -233940.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -2011417.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -11417.00
MRZ.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -233940.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 1198253.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1822722.00
MRZ.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2190090.00
MRZ.V income_statement (quarterly, 2025-12-31) — Normalized Income: -2271608.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1379880.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1789075.00
MRZ.V income_statement (quarterly, 2025-12-31) — Operating Income: -2264711.00
MRZ.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 88540939.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1136233.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 22327846.00
MRZ.V income_statement (quarterly, 2025-12-31) — Other Gand A: 77187.00
MRZ.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 2490500.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 80002.00
MRZ.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 227043.00
MRZ.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1915759.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 262904.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 34661.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 93404.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 847480.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 72786.00
MRZ.V income_statement (quarterly, 2025-12-31) — Pretax Income: -8151.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Receivables: 82513.00
MRZ.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 16194.00
MRZ.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 16195.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -11417.00
MRZ.V income_statement (quarterly, 2025-12-31) — Research And Development: 70682.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -97750691.00
MRZ.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 52717.00
MRZ.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 132172.00
MRZ.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 262076.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 88540939.00
MRZ.V income_statement (quarterly, 2025-12-31) — Special Income Charges: 1810640.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 40117.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1822722.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1822722.00
MRZ.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MRZ.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 6226.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 3832263.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1822722.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 1162061.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1822722.00
MRZ.V income_statement (quarterly, 2025-12-31) — Total Expenses: 2264711.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2009541.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1336918.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MRZ.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 178126.00
MRZ.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 2263457.00
MRZ.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2263457.00
MRZ.V cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -25947.00
MRZ.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 485804.00
MRZ.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 2755848.00
MRZ.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1071741.00
MRZ.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 82942164.00
MRZ.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.02
MRZ.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2246642.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 6578.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 77277068.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 893416.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 991783.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 507208.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 4876.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1867439.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 83094.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: 124794.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 184309.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 101215.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1355355.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 77277068.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9329.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: -499.00
MRZ.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 15305.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 1075078.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6578.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Current Debt: 1686301.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1692879.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2623453.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Depreciation: 15304.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 15304.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 15304.00
MRZ.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 82942164.00
MRZ.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.02
MRZ.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1831362.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 30620.00
MRZ.V income_statement (quarterly, 2026-03-31) — EBIT: -1805632.00
MRZ.V income_statement (quarterly, 2026-03-31) — EBITDA: -1790328.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 2129.00
MRZ.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 893416.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 374755.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 507208.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1867439.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
MRZ.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 699218.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 22314314.00
MRZ.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 86992.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2254690.00
MRZ.V income_statement (quarterly, 2026-03-31) — Gross Profit: -15305.00
MRZ.V income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: -105160.00
MRZ.V income_statement (quarterly, 2026-03-31) — Interest Expense: 25730.00
MRZ.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 25730.00
MRZ.V income_statement (quarterly, 2026-03-31) — Interest Income: 5189.00
MRZ.V income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 5189.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 4876.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1695630.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 4876.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 374755.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 374755.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: -499.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -11417.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 104126.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -499.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 792885.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 4991.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1831362.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1831362.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -45609.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 488583.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -11417.00
MRZ.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -45609.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 1182949.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 500000.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 9329.00
MRZ.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2594706.00
MRZ.V income_statement (quarterly, 2026-03-31) — Normalized Income: -2635740.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1867439.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 4991.00
MRZ.V income_statement (quarterly, 2026-03-31) — Operating Income: -2771153.00
MRZ.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 88597189.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1686301.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 22314314.00
MRZ.V income_statement (quarterly, 2026-03-31) — Other Gand A: 58562.00
MRZ.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 985400.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -238948.00
MRZ.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 181022.00
MRZ.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2590313.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Other Properties: 262904.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Other Receivables: 22818.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 98367.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 930574.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 24557.00
MRZ.V income_statement (quarterly, 2026-03-31) — Pretax Income: -1831362.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Receivables: 58738.00
MRZ.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 15305.00
MRZ.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 15304.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -11417.00
MRZ.V income_statement (quarterly, 2026-03-31) — Research And Development: 21305.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -99582053.00
MRZ.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 28430.00
MRZ.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 57238.00
MRZ.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 144230.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 88597189.00
MRZ.V income_statement (quarterly, 2026-03-31) — Special Income Charges: 105160.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3230.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 9329.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9329.00
MRZ.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MRZ.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 5300.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 2632782.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 9329.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 1692879.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 9329.00
MRZ.V income_statement (quarterly, 2026-03-31) — Total Expenses: 2771153.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2623453.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1557704.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MRZ.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 25068.00
MRZ.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: 804378.00
MRZ.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 804378.00
MRZ.V cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -4963.00
MRZ.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -1548375.00
MRZL.V balance_sheet (annual, 2021-10-31) — Accumulated Depreciation: -719722.69
MRZL.V balance_sheet (annual, 2021-10-31) — Buildings And Improvements: 326515.19
MRZL.V cash_flow (annual, 2021-10-31) — Change In Receivables: -291215.84
MRZL.V cash_flow (annual, 2021-10-31) — Deferred Income Tax: -383257.72
MRZL.V cash_flow (annual, 2021-10-31) — Deferred Tax: -383257.72
MRZL.V cash_flow (annual, 2021-10-31) — Depreciation: 0.00
MRZL.V income_statement (annual, 2021-10-31) — Depreciation Amortization Depletion Income Statement: 0.00
MRZL.V income_statement (annual, 2021-10-31) — Depreciation And Amortization In Income Statement: 0.00
MRZL.V income_statement (annual, 2021-10-31) — Depreciation Income Statement: 0.00
MRZL.V balance_sheet (annual, 2021-10-31) — Dueto Related Parties Current: 19769.48
MRZL.V balance_sheet (annual, 2021-10-31) — Land And Improvements: 129297.64
MRZL.V balance_sheet (annual, 2021-10-31) — Leases: 274968.99
MRZL.V cash_flow (annual, 2021-10-31) — Net Investment Purchase And Sale: 0.00
MRZL.V cash_flow (annual, 2021-10-31) — Net Other Investing Changes: -3558983.11
MRZL.V balance_sheet (annual, 2021-10-31) — Other Current Liabilities: 49919.80
MRZL.V balance_sheet (annual, 2021-10-31) — Other Short Term Investments: 56841.43
MRZL.V income_statement (annual, 2021-10-31) — Other Special Charges: 627.00
MRZL.V cash_flow (annual, 2021-10-31) — Sale Of Investment: 0.00
MRZL.V income_statement (annual, 2021-10-31) — Selling And Marketing Expense: 225113.69
MRZL.V income_statement (annual, 2021-10-31) — Tax Provision: -383257.72
MRZL.V income_statement (annual, 2022-10-31) — +Operating Expense: 1452563.72
MRZL.V income_statement (annual, 2022-10-31) — +Total Revenue: 0.00
MRZL.V balance_sheet (annual, 2022-10-31) — Accounts Payable: 1478851.50
MRZL.V balance_sheet (annual, 2022-10-31) — Accumulated Depreciation: -438606.95
MRZL.V cash_flow (annual, 2022-10-31) — Asset Impairment Charge: 0.00
MRZL.V income_statement (annual, 2022-10-31) — Basic Average Shares: 90447197.00
MRZL.V income_statement (annual, 2022-10-31) — Basic EPS: -0.01
MRZL.V cash_flow (annual, 2022-10-31) — Beginning Cash Position: 3744101.32
MRZL.V balance_sheet (annual, 2022-10-31) — Buildings And Improvements: 348714.39
MRZL.V balance_sheet (annual, 2022-10-31) — Capital Lease Obligations: 171079.55
MRZL.V balance_sheet (annual, 2022-10-31) — Capital Stock: 111721632.71
MRZL.V balance_sheet (annual, 2022-10-31) — Cash And Cash Equivalents: 589854.13
MRZL.V balance_sheet (annual, 2022-10-31) — Cash Cash Equivalents And Short Term Investments: 626574.14
MRZL.V balance_sheet (annual, 2022-10-31) — Cash Financial: 589854.13
MRZL.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Financing Activities: 2680801.86
MRZL.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Investing Activities: -4946309.99
MRZL.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Operating Activities: -888739.06
MRZL.V cash_flow (annual, 2022-10-31) — Change In Account Payable: 55295.27
MRZL.V cash_flow (annual, 2022-10-31) — Change In Payable: 77223.96
MRZL.V cash_flow (annual, 2022-10-31) — Change In Payables And Accrued Expense: 77223.96
MRZL.V cash_flow (annual, 2022-10-31) — Change In Prepaid Assets: 430624.64
MRZL.V cash_flow (annual, 2022-10-31) — Change In Receivables: -298657.62
MRZL.V cash_flow (annual, 2022-10-31) — Change In Working Capital: 209190.98
MRZL.V cash_flow (annual, 2022-10-31) — Changes In Cash: -3154247.19
MRZL.V balance_sheet (annual, 2022-10-31) — Common Stock: 111721632.71
MRZL.V balance_sheet (annual, 2022-10-31) — Common Stock Equity: 82189711.43
MRZL.V cash_flow (annual, 2022-10-31) — Common Stock Issuance: 2607019.72
MRZL.V income_statement (annual, 2022-10-31) — Cost Of Revenue: 21893.09
MRZL.V balance_sheet (annual, 2022-10-31) — Current Assets: 2090891.48
MRZL.V balance_sheet (annual, 2022-10-31) — Current Capital Lease Obligation: 31242.72
MRZL.V balance_sheet (annual, 2022-10-31) — Current Debt And Capital Lease Obligation: 31242.72
MRZL.V balance_sheet (annual, 2022-10-31) — Current Liabilities: 1693313.12
MRZL.V cash_flow (annual, 2022-10-31) — Deferred Income Tax: -666160.80
MRZL.V cash_flow (annual, 2022-10-31) — Deferred Tax: -666160.80
MRZL.V cash_flow (annual, 2022-10-31) — Depreciation: 21893.09
MRZL.V cash_flow (annual, 2022-10-31) — Depreciation Amortization Depletion: 21893.09
MRZL.V income_statement (annual, 2022-10-31) — Depreciation Amortization Depletion Income Statement: 21893.09
MRZL.V cash_flow (annual, 2022-10-31) — Depreciation And Amortization: 21893.09
MRZL.V income_statement (annual, 2022-10-31) — Depreciation And Amortization In Income Statement: 21893.09
MRZL.V income_statement (annual, 2022-10-31) — Depreciation Income Statement: 21893.09
MRZL.V income_statement (annual, 2022-10-31) — Diluted Average Shares: 90447197.00
MRZL.V income_statement (annual, 2022-10-31) — Diluted EPS: -0.01
MRZL.V income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: -830674.72
MRZL.V balance_sheet (annual, 2022-10-31) — Duefrom Related Parties Current: 0.00
MRZL.V balance_sheet (annual, 2022-10-31) — Dueto Related Parties Current: 151220.78
MRZL.V income_statement (annual, 2022-10-31) — EBIT: -818319.53
MRZL.V income_statement (annual, 2022-10-31) — EBITDA: -796426.43
MRZL.V cash_flow (annual, 2022-10-31) — End Cash Position: 589854.13
MRZL.V cash_flow (annual, 2022-10-31) — Financing Cash Flow: 2680801.86
MRZL.V cash_flow (annual, 2022-10-31) — Free Cash Flow: -888739.06
MRZL.V cash_flow (annual, 2022-10-31) — Gain Loss On Investment Securities: 1541.82
MRZL.V income_statement (annual, 2022-10-31) — Gain On Sale Of Security: -31480.36
MRZL.V balance_sheet (annual, 2022-10-31) — Gains Losses Not Affecting Retained Earnings: 11905970.64
MRZL.V income_statement (annual, 2022-10-31) — General And Administrative Expense: 1036584.60
MRZL.V balance_sheet (annual, 2022-10-31) — Gross PPE: 82278733.78
MRZL.V income_statement (annual, 2022-10-31) — Gross Profit: -21893.09
MRZL.V income_statement (annual, 2022-10-31) — Insurance And Claims: 14469.88
MRZL.V income_statement (annual, 2022-10-31) — Interest Expense: 12355.19
MRZL.V income_statement (annual, 2022-10-31) — Interest Expense Non Operating: 12355.19
MRZL.V income_statement (annual, 2022-10-31) — Interest Income: 21456.84
MRZL.V income_statement (annual, 2022-10-31) — Interest Income Non Operating: 21456.84
MRZL.V balance_sheet (annual, 2022-10-31) — Invested Capital: 82189711.43
MRZL.V cash_flow (annual, 2022-10-31) — Investing Cash Flow: -4946309.99
MRZL.V cash_flow (annual, 2022-10-31) — Issuance Of Capital Stock: 2607019.72
MRZL.V balance_sheet (annual, 2022-10-31) — Land And Improvements: 138088.36
MRZL.V balance_sheet (annual, 2022-10-31) — Leases: 293663.65
MRZL.V balance_sheet (annual, 2022-10-31) — Long Term Capital Lease Obligation: 139836.83
MRZL.V balance_sheet (annual, 2022-10-31) — Long Term Debt And Capital Lease Obligation: 139836.83
MRZL.V cash_flow (annual, 2022-10-31) — Long Term Debt Payments: -28930.57
MRZL.V cash_flow (annual, 2022-10-31) — Net Common Stock Issuance: 2607019.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income Common Stockholders: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income Continuous Operations: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: -830674.72
MRZL.V cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: -830674.72
MRZL.V income_statement (annual, 2022-10-31) — Net Interest Income: 9101.65
MRZL.V cash_flow (annual, 2022-10-31) — Net Investment Purchase And Sale: 180.24
MRZL.V cash_flow (annual, 2022-10-31) — Net Issuance Payments Of Debt: -28930.57
MRZL.V cash_flow (annual, 2022-10-31) — Net Long Term Debt Issuance: -28930.57
MRZL.V income_statement (annual, 2022-10-31) — Net Non Operating Interest Income Expense: 9101.65
MRZL.V cash_flow (annual, 2022-10-31) — Net Other Financing Charges: 102712.71
MRZL.V cash_flow (annual, 2022-10-31) — Net Other Investing Changes: -4946490.23
MRZL.V balance_sheet (annual, 2022-10-31) — Net PPE: 81840126.83
MRZL.V balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 82189711.43
MRZL.V income_statement (annual, 2022-10-31) — Normalized EBITDA: -764946.07
MRZL.V income_statement (annual, 2022-10-31) — Normalized Income: -799194.36
MRZL.V cash_flow (annual, 2022-10-31) — Operating Cash Flow: -888739.06
MRZL.V cash_flow (annual, 2022-10-31) — Operating Gains Losses: 1541.82
MRZL.V income_statement (annual, 2022-10-31) — Operating Income: -1474456.81
MRZL.V income_statement (annual, 2022-10-31) — Operating Revenue: 0.00
MRZL.V balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 46817042.00
MRZL.V balance_sheet (annual, 2022-10-31) — Other Current Liabilities: 31998.13
MRZL.V balance_sheet (annual, 2022-10-31) — Other Equity Interest: 102712.71
MRZL.V income_statement (annual, 2022-10-31) — Other Gand A: 681263.25
MRZL.V income_statement (annual, 2022-10-31) — Other Income Expense: 634680.44
MRZL.V cash_flow (annual, 2022-10-31) — Other Non Cash Items: 12355.19
MRZL.V balance_sheet (annual, 2022-10-31) — Other Non Current Assets: 91843.08
MRZL.V income_statement (annual, 2022-10-31) — Other Non Operating Income Expenses: 666160.80
MRZL.V income_statement (annual, 2022-10-31) — Other Operating Expenses: 168459.72
MRZL.V balance_sheet (annual, 2022-10-31) — Other Properties: 81498267.38
MRZL.V balance_sheet (annual, 2022-10-31) — Other Short Term Investments: 36720.01
MRZL.V income_statement (annual, 2022-10-31) — Other Special Charges: 4837.00
MRZL.V income_statement (annual, 2022-10-31) — Other Taxes: 5553.06
MRZL.V balance_sheet (annual, 2022-10-31) — Payables: 1630072.28
MRZL.V balance_sheet (annual, 2022-10-31) — Payables And Accrued Expenses: 1630072.28
MRZL.V balance_sheet (annual, 2022-10-31) — Prepaid Assets: 813045.44
MRZL.V income_statement (annual, 2022-10-31) — Pretax Income: -830674.72
MRZL.V balance_sheet (annual, 2022-10-31) — Receivables: 651271.89
MRZL.V income_statement (annual, 2022-10-31) — Reconciled Cost Of Revenue: 21893.09
MRZL.V income_statement (annual, 2022-10-31) — Reconciled Depreciation: 21893.09
MRZL.V cash_flow (annual, 2022-10-31) — Repayment Of Debt: -28930.57
MRZL.V balance_sheet (annual, 2022-10-31) — Retained Earnings: -41540604.62
MRZL.V income_statement (annual, 2022-10-31) — Salaries And Wages: 340851.47
MRZL.V cash_flow (annual, 2022-10-31) — Sale Of Investment: 180.24
MRZL.V income_statement (annual, 2022-10-31) — Selling And Marketing Expense: 241966.33